A solid-phase enzyme-immunoassay for the determination of the digitoxin concentration in human serum (Enzymun-Test® Digitoxin) was developed, and subsequently evaluated in seven laboratories. The test is based on the competition principle. Polystyrene tubes coated with anti-digitoxin antibodies (from sheep) were used äs the solid phase. In the concentration ränge 10-40 g/l, the coefflcient of Variation for the majority of laboratories was between 2 and 7%. The day-to-day precision only slightly differed from the within-run precision. The measuring ränge was between 4 and 60 g/l. Enzymun-Test® Digitoxin showed good agreement with three known methods for digitoxin determination. No influence on the values was observed in lipaemic, uraemic and icteric samples, dysproteinaemia sera and in the presence of various digoxin derivatives. The new enzyme-immunoassay pennits the practical and reliable determination of serum digitoxin and is suited for use in routine analysis. 
Introduction
Provided that suitable sampling times and sampling conditions are used, the determination of glycoside concentrations in human serum provides useful Information on the actual intake, the distribution and the excretion of Digitalis glycosides. Digitoxin determinations help on the one hand to avoid dangerous long term effects resulting from the comparatively long half-life of digitoxin (l, 2), and on the other hand enable an improved assessment of severe intoxications (3, 4) .
Measurement of serum glycoside concentrations yields only a limited amount of Information, however, on the myocardial uptake of the glycoside and the degree of receptor-binding of the glycoside and its active metabolites, which in the final reckoning is responsible for the action of digitalis. The validity of the Information obtained from measurements of the glycoside concentration can be further restricted by additional unexpected and possibly rapidly changing pathological conditions, e. g. renal failure, thyroid gland dysfunctions and derangement of the electrolyte and water balance (3 -6) .
In addition to the already known immunoassays for determining digitoxin in serum (6 -9), a new enzymeimmunoassay has recently been presented (10). The investigation of this test (Enzymun-Text® Digitoxin) in 7 laboratories is described here.
Methods and Materials
Test principle and test procedure for Enzymun-Test® Digitoxin 1 )
Enzymun-Test® Digitoxin is an enzyme-immunosassay based on the competition principle. The digitoxin from the serum sample (20 μΐ) and the digitoxin conjugate (l ml, digitoxin Sample material and quality control
Human sera from normal donors and patients receiving digitoxin therapy were used for the investigations; fresh sera were used for investigating within-series precision, linearity and interference, whereas deep-frozen sera were used for investigating day-to-day precision and carrying out method comparisons. The control serum contained in the Enzymun-Test® Digitoxin pack was also analysed for quality control purposes. In the method comparisons, the control sera recommended by the respective manufacturers were used.
Participants, reagents and equipment
The laboratories taking part in the study are designated with the letters A to G. Results from the Boehringer Mannheim laboratories have been given the letter H. The order of appearance of the authors' names on the title page of this paper does not correspond to the sequence A to G. Within the scope of a collaborative study, all of the participants determined three "unknown" human serura-based, lyophilized specimens containing different digitoxin concentrations (duplicate measurements on different 10 days).
4. The specificity of the digitoxin antibody was checked with the digitoxin-like compounds listed in table 4. The interference of 43 commonly used drugs was investigated in vitro using twice the toxic concentrations according to 1. c. (12) . Lipaemic, uraemic and icteric (up to 171 μηιοΐ/ΐ bilirubin) sera were included in the method comparison studies with the reagents named above.
In order to check the possibility of interference by haemolysis, human serum containing 14 μg/l digitoxin was spiked stepwise with haemolysate up to a final concentration of 20 g/l Hb.
The influence of various human sera with pathologically altered protein concentrations (see tab. 3) was investigated by a stepwise blending with a human serum having a high digitoxin concentration.
For the method comparisons, two radioimmunoassays and a fluorescence Polarisation immunoassay were used:
Coat-A-Count, This reagent contains catalase (= 150 kU/1) in an acetate buffer (50 mmol/1, pH 5.5) and 5 g/l detergent. By adding 0.1 ml of the stop reagent to l ml of Substrate buffer solution, the oxidation of the chromogen ABTS® is interrupted, while at the same time the coloured ABTS® radical is stabilised. -Recovery of digitoxin in a (digitoxin-free) human serum after spiking with definite amounts of the 60 μg/l digitoxin Standard. Recovery was checked by visual inspection of the graphic presentation obtained by plotting found concentrations s a function of dilution.
-Comparison studies with human sera covering a widc r nge of concentrations with three other frequently used tests (t b. 2).
Statistical evaluation was performcd according to the standardised principle component analysis (13, 14) .
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Results and Discussion

Precision
Depending upon the concentration, the majority of coefficients of Variation were between 2 and 7% with the day-to-day scatter being only slightly higher than within series ( figs. l and 2) . The test System hence shows good precision in the central concentration r nge from about 10 to 40 μg/l.
When the timing cycles are carefully observed, the values measured manually show precision similar to that obtained with the ES 22. The procedure is simplified by the stop reagent, which removes the need for careful timing of spectrometric measurements.
Analytical r nge limits
In the determination of the lower detection limit values between l and 2 μg/l were obtained, with values down to l μg/l using the ES 22. Imprecision studies in that concentration r nge yielded coefficients of Variation of 39% (2 μg/l) and 9% (4 μg/l). Thus the diagnostically useful measuring r nge extends from 4 μg/l to 60 μg/l (highest Standard) digitoxin.
Collaborative study
The results of the collaborative, interlaboratory tri l (tab. 4) show interlaboratory coefficients of Variation of 4.6%, 5.6% and 6.9% for the three samples used. These data document a good comparability of values from one laboratory to another.
Specificity
The results shown in table 5 show that the wallbound digitoxin antibodies are highly specific (laboratory H): The metabolites of digitoxin showed cross-reactions of 80 to 100%, whereas all of the digoxin derivatives showed cross-reactions of less than 2%. Cross-reactions of 53% and 41% respectively were shown by the alpha-and beta-forms of Haemoglobin did not interfere up to the highest concentration tested (20 g/l, 'see fig. 6 ).
No interferences were observed in the investigations of four human sera containing pathologically altered protein concentrations. The results obtained with the serum from patient 2 (see tab. 3) are shown in figure 7 .
Conclusions
These studies show that Enzymun-Test® Digitoxin produces values for digitoxin that are largely free from interference and which are in good agreement with the results from other eommerci lly available tests. This test is an alternative to radioimmunological methods, and enables the reliable and simple determin tion of digitoxin, also in smaller routine laboratories. 
